From Turkey to Tajikistan, Bangladesh to Bahrain, and Russia to Rwanda, multinational pharma firms are increasingly situating wide-ranging management…

The United Arab Emirates’ Cabinet, the de facto executive branch of the federation, recently announced a set of decisions and legislation to support…

Pierre Fabre, the French dermo-cosmetics giant, is banking on its tradition of quality to continue disrupting the emerging markets. Naim Hanna,…

With a relatively high number of genetic disorders, the Arab population of the United Arab Emirates (UAE) is increasingly becoming the subject of new…

Saudi Arabia is aiming to become a more attractive investment destination for multinational pharma companies through economic development projects…

Paolo Carli, head of Middle East, Africa, Turkey, Russia and CIS (MEAR) for Merck has continually taken on greater responsibilities in the Middle…

Khaled Elrefae, Middle East and Africa Specialty Care Operations Head (GM) for Ipsen, highlights Ipsen’s impressive internationalization strategy…

Since we last met with Paolo Carli in 2013, he has been given greater responsibilities within Merck and is now Head of Middle East, Africa, Turkey,…

The UAE ranks as a world leader in rapid drug approvals with its fast-track registration system that accelerates the process and eliminates long…

PharmaBoardroom highlights three pharma executives whose experience in the Middle East has served to propel them into global leadership positions.…

The top 10 pharma companies in the UAE ranked by 2018 sales according to IQVIA data. Swiss giant Novartis leads the way with USD 196 million in sales,…

As the general manager of Menarini Thailand, Thomas Scott Birsinger shares the importance of the Thai affiliate within the company’s operations in…